The researchers compared data for 168 African-American women and 997 Caucasian women with advanced or recurrent endometrial cancer.
The investigators found that African-American patients were significantly more likely than Caucasian patients to have advanced stage disease and more aggressive tumor types. Both African-American women and Caucasian women received similar treatment regimens of chemotherapy.
In addition, Maxwell's team found that overall survival was significantly worse among African-American women -- an average of 10.6 months compared with 12.2 months for Caucasians. Even after investigators controlled for characteristics such as age, disease status and tumor grade and treatment, African-American patients still had shorter survival times.
Presented at the Society of Gynecologic Oncologists' 36th Annual Meeting on Women's Cancer, 3/05
Original source: Reuters Health
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.